Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.
Article Details
- CitationCopy to clipboard
Rettie AE, Wienkers LC, Gonzalez FJ, Trager WF, Korzekwa KR
Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.
Pharmacogenetics. 1994 Feb;4(1):39-42.
- PubMed ID
- 8004131 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Pharmaco-genomics
Drug Interacting Gene/Enzyme Allele name Genotypes Defining change(s) Type(s) Description Details Phenytoin Cytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712CYP2C9*2 Not Available - 430C>T (rs1799853)
Effect Inferred Poor drug metabolizer, lower dose requirements Details Celecoxib Cytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712CYP2C9*2 Not Available - 430C>T (rs1799853)
Effect Inferred Poor drug metabolizer, lower dose requirements Details Clopidogrel Cytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712CYP2C9*2 Not Available - 430C>T (rs1799853)
Effect Inferred Poor drug metabolizer, lower dose requirements, higher risk for drug-drug interactions Details Acetylsalicylic acid Cytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712CYP2C9*2 Not Available - 430C>T (rs1799853)
Effect Inferred Poor drug metabolizer, lower dose requirements Details Glipizide Cytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712CYP2C9*2 Not Available - 430C>T (rs1799853)
Effect Inferred Poor drug metabolizer, lower dose requirements Details Tolbutamide Cytochrome P450 2C9
Gene symbol: CYP2C9
UniProt: P11712CYP2C9*2 Not Available - 430C>T (rs1799853)
Effect Inferred Poor drug metabolizer, lower dose requirements Details